Navigation Links
MRI better than MDCT in detecting endoleaks, study says

Contrast-enhanced MR imaging is significantly superior to 16 slice multidetector CT in the detection of endoleaks after endovascular repair of abdominal aortic aneurisms (EVAR), according to a recent study conducted by researchers at Ospedale San Giovanni in Bellinzona, Switzerland.

Endovascular repair of abdominal aortic aneurysms has become a viable alternative treatment to open surgery for many patients. Endoleak development represents a complication of endovascular aortic aneurysm repair and is characterized by blood flow outside the stent-graft lumen but within the aneurysm sac, said Rolf Wyttenbach, MD, lead author of the study. Patients after EVAR need livelong imaging surveillance to detect endoleaks. CT is most commonly used for imaging follow-up of these patients. , A few prior studies suggested that MRI may be superior to CT for the detection of endoleaks. However, these studies mostly used single or 4-row MDCT and standard gadolinium contrast media for MR imaging, he said.

The study consisted of 43 patients who had undergone EVAR. Each of the patients had both MDCT and MRI within one week of the procedure. According to the study, MRI was performed using a high relaxivity contrast medium and for MDCT, an iodine containing agent was used. Upon the completion of the study, two observers evaluated MRI and MDCT separately.

The study showed that 21 endoleaks were detected in 18 patients. Sensitivity, specificity and accuracy for endoleak detection were 100%, 96% and 98% for reader 1 and 90%, 81% and 85% for reader 2 on MRI and 48%, 96% and 74% for both readers on MDCT.

The results indicate that MR is a good choice for diagnosing endoleaks. In addition, MRI does not expose the patients to radiation and the MR contrast agent is less nephrotoxic in the clinically used dose compared to iodinated contrast agents used for CT. For this reason MRI may become a preferred imaging modality to follow-up patients after endovascular aneurysm repair, said Dr. Wyttenbach.


Contact: Necoya Tyson
American Roentgen Ray Society

Related medicine news :

1. Boston College biologists build a better mouse model for cancer research
2. Two Liver Cancer Treatments Better Than One
3. Know Your Personal Genetic Health to Age Better Now!
4. AAPPO Releases Diabetes Toolkit to Spur Action on Better Diabetes Care
5. Better care for dementia patients through new funding
6. Better-Educated Smokers More Likely to Quit After Seeing Ads
7. AMICAS and RIA Partner for Better Customer Service in Radiology
8. Medicare Advantage Plans Have New, Better Way to Access CMS Data
9. Genomic Profiling of Breast Cancers a Better Treatment Tool
10. Two Drugs Better Than One for High Blood Pressure
11. New Drugs No Better Than Older Ones for Schizophrenia
Post Your Comments:
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... 2016 , ... National recruitment firm Slone Partners is pleased to ... genomics experience, as Vice President of North American Capital Sales at HTG Molecular ... the sales team in the commercialization of the HTG EdgeSeq system and associated reagents ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology: